Overview
This study aims to evaluate whether incorporating FeNO monitoring into routine pediatric asthma care improves clinical outcomes relative to a historical cohort managed without FeNO
Eligibility
Inclusion Criteria:
- Children aged 6 to 14 years with a physician-diagnosed asthma.
- Minimum of three months' follow-up at the pediatric respiratory clinic.
- Availability of Asthma Control Test (ACT/C-ACT) scores and clinical data
Exclusion Criteria:
- Presence of other chronic pulmonary diseases (e.g., cystic fibrosis).
- Recent respiratory infections within four weeks prior to enrollment.
- Current treatment with biologic agents affecting asthma inflammation.
